<\/p>\n
Latest Prevention & Wellness News<\/h3>\n
\n<\/p>\n<\/div>\n
THURSDAY, Sept. 3, 2020 — Just over 54% of Americans now say they would get a COVID-19<\/a> vaccine<\/a> in the first 12 months after it’s introduced, a significant increase from 42% in July, a new WebMD<\/i> poll finds.<\/p>\n However, only 27% of the 1,000 readers who participated in the survey said they’d get a vaccine<\/a> within the first three months after it becomes available, which is just slightly higher than 26% who said so in the July poll.<\/p>\n In the new survey, 12.5% of respondents said they wouldn’t get a vaccine at all, and 21.4% said they’re unsure.<\/p>\n For any COVID-19<\/a> vaccine to be approved by the U.S. Food and Drug Administration, it has to prevent or reduce the severity of infection in at least 50% of people who receive it.<\/p>\n But only 8.8% of survey participants said they consider that 50% standard effective, with 65.2% saying a vaccine should be 75% to 99% effective to be approved by the FDA, WebMD<\/i> reported.<\/p>\n Only 25.6% of respondents said they would get a vaccine that was 50% effective, 35.5% said they wouldn’t get the vaccine, 25.6% said maybe and 13.3% said they weren’t sure.<\/p>\n “We already know that people are worried about getting a COVID vaccine, and understanding how well the vaccine works could be another hurdle for patients,” said Dr. John Whyte, chief medical officer of WebMD<\/i>. “Public health officials face a tough challenge explaining to consumers what this vaccine can and can’t do.”<\/p>\n There are more than 170 potential COVID-19<\/a> vaccines<\/a> being developed wordwide, with 142 in preclinical evaluations and 31 in clinical trial, according to WebMD<\/i>.<\/p>\n ![\"MedicalNews\"](\"https:\/\/images.medicinenet.com\/images\/HealthDay\/healthday.png\")
Copyright \u00a9 2019 HealthDay. All rights reserved.<\/p>\n
\n
\n ![](\"https:\/\/images.medicinenet.com\/\/images\/slideshow\/pertussis-whooping-cough-s1-girl-cough-in-bed.jpg\"\/)
\n